Peptide library
Longevity

Epitalon

Tetrapeptide studied in telomerase/aging research.

Emerging Research

Evidence Level

Emerging

Mechanism4/10
Safety Clarity5/10
Research Popularity7/10

Research Type

AnimalHuman

/ System Mapping

Where this compound appears in research pathways

Research-only note: This mapping is educational and does not represent a treatment protocol.

/ 01

Overview

Tetrapeptide studied in telomerase/aging research.

/ 02

Mechanism of Action

Studied for pineal/telomerase pathway modulation.

/ 03

Research Applications

Aging biology research.

Studied for, research explores, preclinical models suggest, clinical studies have investigated.

/ 04

Studied Research Contexts

AnimalHuman

/ 05

Studied Research Dosing Ranges

Limited public data on dosing ranges across research models.

Dosing varies by study design and is not a recommendation for human use.

/ 06

Potential Adverse Effects Reported in Research

Adverse effect data is limited. Many compounds in this database lack human safety profiles.

/ 07

Mechanism Deep Dive

Epitalon is a synthetic tetrapeptide studied for telomerase-related biology, pineal-aging interactions, and cellular aging markers. Mechanistic claims focus on telomere-related cell biology and gene expression in aging models.

/ 08

Pathway Role

Sits within cellular aging and telomere-related pathways in preclinical and limited clinical aging research.

/ 09

Biological Targets

Telomerase activity (preclinical)Telomere length markersPineal gland aging biologyCellular senescence markers

/ 10

Research Applications

  • Cellular aging biomarker studies
  • Pineal aging models

/ 11

Evidence Summary

Emerging and controversial. Some animal data is mixed, including studies showing no effect on mean lifespan in mice.

Evidence Level Rationale

Rated emerging/controversial due to inconsistent preclinical results and lack of robust human anti-aging outcome trials.

/ 12

Research Observation Timeline

Early Signal Window

Cellular marker changes in vitro within days to weeks

Primary Study Window

Weeks to months in aging biomarker studies

Endpoint Type

Cellular and biomarker aging endpoints

Evidence Strength

Emerging / controversial

No reliable human anti-aging timeline. Animal lifespan data is mixed.

/ 13

Safety & Unknowns

Human long-term safety and outcome data are not well-characterized in controlled studies.

/ 14

Research Limitations

No reliable human anti-aging timeline. Some animal lifespan data is null or mixed.

/ 15

References

References are being curated from peer-reviewed literature.

/ 07

Evidence Score

Mechanism Confidence4/10
Safety Clarity5/10
Research Popularity7/10

Overall Research Confidence

Emerging

Reflects breadth of mechanism, study type, and reproducibility across research literature.

Appears in pathways

For research and educational purposes only.

Not medical advice. Not intended to diagnose, treat, cure, or prevent disease. Compounds discussed may not be approved for human use. Any dosing information shown describes ranges studied in research settings — never a recommendation.